Healthcare Press Czech Republic
SEE OTHER BRANDS

The best news from Czechia on health and wellness

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Press Czech Republic.

Exploring New Horizons in Psychotherapy: A Groundbreaking Study on Indigenous Healing and Western Client Experiences

Exploring New Horizons in Psychotherapy: A Groundbreaking Study on Indigenous Healing and Western Client Experiences

PRAHA, ČESKá REPUBLIKA, CZECH REPUBLIC, October 11, 2024 /⁨EINPresswire.com⁩/ -- A recent study published in Explore journal sheds light on an emerging trend in mental health care: the integration of Indigenous healing techniques into Western...

Carboxy Therapy Market Huge Growth, Rising Demand  and Future Scope 2025-2032 | Oxxot, UNITRONIC, DermoEquipos, BodyHt

Carboxy Therapy Market Huge Growth, Rising Demand and Future Scope 2025-2032 | Oxxot, UNITRONIC, DermoEquipos, BodyHt

BURLINGAME, CA, UNITED STATES, February 7, 2025 /⁨EINPresswire.com⁩/ -- The Global Carboxy Therapy Market to grow at a CAGR of 11.4% (2025 - 2032) 𝐓𝐡𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 𝐨𝐟 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐛𝐲 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐨𝐟...

The European Magazine Announces Award Winners 2025

The European Magazine Announces Award Winners 2025

The European Magazine has announced the recipients of their 2025 awards who have won titles up to this point in the year. LONDON, UNITED KINGDOM, April 11, 2025 /⁨EINPresswire.com⁩/ -- The European is proud to announce the final full list of...

Joe Bonamassa’s Highly Anticipated Fall 2025 U.S. Tour On Sale Now

Joe Bonamassa’s Highly Anticipated Fall 2025 U.S. Tour On Sale Now

Official New Music Video Released For The Latest Single “Breakthrough” NASHVILLE, TN, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Blues-rock titan Joe Bonamassa has announced his highly anticipated Fall 2025 U.S. Tour, bringing his...

Unwording: An Immersive Journey Into Negative Thought Patterns

Unwording: An Immersive Journey Into Negative Thought Patterns

Experience Tom’s heartfelt puzzle adventure, now available on PlayStation and Xbox. PILSEN, CZECH REPUBLIC, December 19, 2024 /⁨EINPresswire.com⁩/ -- Mental health struggles touch all of us. Negative thought patterns can cloud our perception of...

Top Driver In Repronex Market 2025: Impact Of Increasing Infertility Rates On The Growth Of The Market

Top Driver In Repronex Market 2025: Impact Of Increasing Infertility Rates On The Growth Of The Market

The Business Research Company's Repronex Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, February 5, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports Released: Trends,...

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

-Subject 1 and Subject 2 experienced durable, clinically meaningful improvements in swallowing at 9-months and 6-months post-BB-301 treatment, respectively, with Subject 2 achieving a Sydney Swallow Questionnaire Score Representative of Clinically...

Drug Trials Snapshots: OMVOH

Drug Trials Snapshots: OMVOH

HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic...

ASB Group launches CE4 Payroll Calculator

ASB Group launches CE4 Payroll Calculator

ASB Group launched its new IT tool, the CE4 Payroll Calculator, which calculates and compares employer costs and salary volumes CZECH REPUBLIC, November 6, 2024 /⁨EINPresswire.com⁩/ -- ASB Group, a leading provider of professional consulting and...

Mondelēz International Reports Q1 2025 Results

Mondelēz International Reports Q1 2025 Results

Net Revenues +0.2%, Organic Net Revenues1 +3.1%, Volume/Mix -3.5% Diluted EPS declined -70.2% to $0.31 Adjusted EPS1 was $0.74 which declined -18.3% on a constant currency basis Cash provided by operating activities was $1.1 billion Free Cash...

Savaria Announces Date for First Quarter 2025 Financial Results

Savaria Announces Date for First Quarter 2025 Financial Results

LAVAL, Quebec, April 28, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces it will release its financial results for the first quarter of 2025 after market close...

US Kaolin Market Size To Grow At A Record 5.00% CAGR By 2032

US Kaolin Market Size To Grow At A Record 5.00% CAGR By 2032

Kaolin is used extensively by the paper industry as a coating and filler substance to enhance print quality. NEW YORK, WA, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- The US Kaolin Market is well-positioned to capitalize on the ongoing...

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia

Jorge Castillo, M.D. to Present Iopofosine I 131 Activity in Bing-Neel Syndrome Andrei Shustov, M.D. to Review CLOVER WaM Pivotal Study FLORHAM PARK, N.J., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage...

Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society

Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society

– Additional positive data from the Company’s completed Phase 1 clinical trial evaluating ENTR-601-44 reinforces its safety profile and supports the planned Q4 2024 global regulatory filings for a Phase 2 clinical trial – – Preclinical data...

IBA Group Participates in SHARE Kansas City 2024

IBA Group Participates in SHARE Kansas City 2024

Visit booth #217 at SHARE Kansas City 2024 and join IBA Group’s sessions to explore the latest advancements in mainframe technology and CI/CD practices PRAGUE, CZECHIA, August 6, 2024 /⁨EINPresswire.com⁩/ -- IBA Group is pleased to announce its...

Identifying Allergens in Cosmetics

Identifying Allergens in Cosmetics

NEW YORK, NY, UNITED STATES, November 20, 2024 /⁨EINPresswire.com⁩/ -- Cosmetic products contain common allergens that are known to trigger skin allergies and significantly irritate the skin. In this new study in SKIN: The Journal of Cutaneous...

New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

Findings from Part B and Part C of the DEVOTE study support the clinical benefits of a higher dose regimen of nusinersen (50/28 mg) in both individuals previously treated and treatment-naïve to nusinersen Investigational regimen also shows more...

Joe Bonamassa Announces New Studio Album ‘Breakthrough’ — A Bold, Genre-Spanning Musical Journey Including 10 New Songs

Joe Bonamassa Announces New Studio Album ‘Breakthrough’ — A Bold, Genre-Spanning Musical Journey Including 10 New Songs

Title Track “Breakthrough” Out Now, Showcasing a New Chapter in Songcraft, Produced By Kevin Shirley LOS ANGELES, CA, UNITED STATES, April 25, 2025 /⁨EINPresswire.com⁩/ -- In a career defined by evolution, Joe Bonamassa is ready to turn the page...

 Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care

Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care

News Release Exclusive Industry Role: Avextra is the industry partner in a groundbreaking project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression. Pioneering Research: This multi-centre Phase 2...

Savaria Declares Monthly Dividend

Savaria Declares Monthly Dividend

LAVAL, Québec, April 22, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS) a global leader in the accessibility industry, declared today a dividend of 4.5 cents ($0.045) per common share, in accordance with its monthly dividend...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service